Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
A total of 100 patients with ST-elevation myocardial infarction (STEMI) presenting slow-flow
after primary-percutaneous coronary intervention (PPCI) will be randomized to pharmacologic
treatment with hyperemic drugs versus flow-mediated hyperemia.